Literature DB >> 2409371

Regression of left ventricular hypertrophy in hypertension: comparative effects of three different drugs.

P J Mace, W A Littler, D R Glover, D B Rowlands, T J Stallard.   

Abstract

We examined the effect of three antihypertensive agents with differing modes of action on blood pressure, heart rate, plasma catecholamines, plasma renin activity, and echocardiographic left ventricular mass. Twenty-six patients were studied; nine were treated with nifedipine, a calcium antagonist, nine were treated with timolol, a nonselective beta-blocker, and eight were treated with indapamide, a diuretic with some probable calcium antagonist properties. All drugs reduced blood pressure satisfactorily; the reduction of systolic blood pressure was not significantly different among the three drugs, but timolol reduced diastolic blood pressure by a greater amount than did either indapamide or nifedipine. Left ventricular (LV) mass was reduced equally by all three drugs. However, there were markedly different effects on the other parameters measured. Heart rate was reduced to a greater extent by timolol than by the other two drugs. Plasma renin activity was reduced by timolol, unchanged by nifedipine, and increased by indapamide. There were no significant changes in either adrenaline or noradrenaline with any of the three drugs. We conclude that these data do not support the hypothesis that the sympathetic nervous system is primarily responsible for left ventricular hypertrophy, and suggest that reduction of left ventricular mass with antihypertensive agents is not the property of any one class of drug.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409371     DOI: 10.1097/00005344-198507002-00011

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

Review 1.  Regression of increased left ventricular mass by antihypertensives.

Authors:  C J Lavie; H O Ventura; F H Messerli
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

Review 2.  Low dose loop diuretics in essential hypertension. Experience with torasemide.

Authors:  I Achhammer; P Metz
Journal:  Drugs       Date:  1991       Impact factor: 9.546

3.  Expression of vascular endothelial growth factor during the development of cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  A M McAinsh; M Geyer; J Fandrey; J C Rüegg; R J Wiesner
Journal:  Mol Cell Biochem       Date:  1998-10       Impact factor: 3.396

Review 4.  Clinical use of beta-adrenoceptor blockade in systemic hypertension.

Authors:  J Nadelmann; W H Frishman
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.